Bristol Myers Squibb Co. (BMY)
59.86
-0.07
(-0.12%)
USD |
NYSE |
Feb 12, 16:00
59.69
-0.17
(-0.28%)
Pre-Market: 06:05
Bristol Myers Squibb Cash from Investing (Quarterly) : -1.458B for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -693.00M |
| Gilead Sciences, Inc. | -1.835B |
| Johnson & Johnson | -4.485B |
| Regeneron Pharmaceuticals, Inc. | 220.30M |
| Janux Therapeutics, Inc. | 8.306M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.974B |
| Cash from Financing (Quarterly) | -6.029B |
| Free Cash Flow | 12.84B |
| Free Cash Flow Per Share (Quarterly) | 0.7859 |
| Free Cash Flow to Equity (Quarterly) | 5.506B |
| Free Cash Flow to Firm (Quarterly) | 1.923B |
| Free Cash Flow Yield | 10.52% |